Cardiology

Ischemic outcomes don't vary with gender in ACS patients

(HealthDay)—For acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) and receiving clopidogrel, prasugrel, or ticagrelor, ischemic outcome does not differ by gender, according to a ...

Cardiology

Warfarin persistence higher than previously reported in A-fib

(HealthDay)—Among patients with atrial fibrillation (AF), the proportion of warfarin persistence is 0.91 at one year and 0.73 at four years, according to a study published online Aug. 27 in Cardiovascular Therapeutics.

Cardiology

Older MI survivors have high event risk over long term

(HealthDay)—Older myocardial infarction (MI) survivors have long-term elevated risks of mortality and cardiovascular events, according to a study published online Aug. 26 in Cardiovascular Therapeutics.

Cardiology

Coenzyme Q10 doesn't prevent periprocedural myocardial injury

(HealthDay)—Pre-treatment with coenzyme Q10 (CoQ10) before elective percutaneous coronary intervention (PCI) does not reduce periprocedural myocardial injury (PMI), but does significantly decrease high-sensitivity C-reactive ...

Cardiology

Lipophilic superior to hydrophilic statin in heart failure

(HealthDay)—For patients with heart failure, treatment effects are superior with lipophilic versus hydrophilic statins, according to a meta-analysis published online Aug. 17 in Cardiovascular Therapeutics.

page 2 from 4